Intraperitoneal Administration

Intraperitoneal Administration is a route of administration involving the delivery of substances directly into the peritoneal cavity, distinguished from other parenteral routes by its access to the intraperitoneal space for systemic or local therapeutic effect.

13.3K

Publications

575.9K

Citations

54.7K

Authors

6.6K

Institutions

Publications per year

2017–2026

1.7K

Authors

54.7K

  1. PH
    Paul H. Sugarbaker

    MedStar Washington Hospital Center, United States

    71 publications · 4.3K citations

    38

    h-index

  2. DL
    David L. Morris

    St George Hospital, Australia

    32 publications · 1.6K citations

    22

    h-index

  3. MM
    Maurie Markman

    Cleveland Clinic, United States

    30 publications · 1.8K citations

    20

    h-index

  4. HI
    Hironori Ishigami

    The University of Tokyo, Japan

    21 publications · 1.2K citations

    18

    h-index

  5. OA
    O. Anthony Stuart

    MedStar Washington Hospital Center, United States

    18 publications · 816 citations

    17

    h-index

1–5 of 54.7K

Venues

  1. PubMed

    Repository · 1.3K publications · 42.2K citations

    82

    h-index

  2. Infection and Immunity

    IAI · 269 publications · 14.5K citations

    67

    h-index

  3. The Journal of Experimental Medicine

    150 publications · 12.6K citations

    61

    h-index

  4. 53

    h-index

  5. Journal of Neurochemistry

    JNC · 129 publications · 6.4K citations

    48

    h-index

1–5